Primary human hepatocytes versus hepatic cell line: Assessing their suitability for in vitro nanotoxicology

Nanotoxicology

Volumn 7, Issue 7, 2013, Pages 1255-1271

  Kermanizadeh, Ali ^a   Gaiser, Birgit K ^a   Ward, Michael B ^b   Stone, Vicki ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cytokine production; Cytotoxicity; Liver; Nanomaterial uptake

Indexed keywords

ALBUMIN; INTERLEUKIN 6; INTERLEUKIN 8; MULTI WALLED NANOTUBE; NANOMATERIAL; SILVER; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; ZINC OXIDE;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LC 50; LIVER CELL; LIVER FUNCTION; NANOTOXICOLOGY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ALBUMINS; ANIMAL TESTING ALTERNATIVES; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; HEPATOCYTES; HUMANS; LETHAL DOSE 50; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PRIMARY CELL CULTURE; SURFACE PROPERTIES; TOXICITY TESTS;

EID: 84885145308     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2012.734341     Document Type: Article

References (35)

1. Anreddy RNR, Devarakonda RK, Vurimindi H, Yellu NR. 2011. In vitro cytotoxicity of carbon nanoparticles against HepG32 cells. Latin Am J Pharm 30:177-180.
2. Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: Sources and toxicity. Biointerpahses 2:18-67.
3. Chen C, Zhang P, Hou X, Chai Z. 1999. Sub-cellular distribution of selenium and Se-containing proteins in human liver. Biochem Biophys Acta 1427:205-215.
4. Delpino MV, Barrionuevo P, Scian R, Fossati CA, Balsi PC. 2010. Brucella-infected heaptocytes mediate potentially tissue-damaging immune responses. J Hepatol 53:145-154.
5. Dong WM, Simeonova PP, Gallucci R, Matheson J, Flood L, Wang SY, et al. 1998. Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicol Appl Pharmacol 151:359-366.
6. Guengerich FP. 2001. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611-650.
7. Hansson PK, Asztely AK, Clapham JC, Schreyer SA. 2004. Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability. Biochem Biophys Acta 1684:54-62.
8. Hoet PHM, Hohlfeld IB, Salata O. 2004. Nanoparticles-known and unknown health risks. J Nanobiotechnology 2:12-27.
9. Jacobsen NR, Pojano G, Wallin H, Jensen KA. 2010. Nanomaterial dispersion protocol for toxicological studies in ENPRA. Internal ENPRA Project Report. The National Research Centre for the Working Environment. pp 6.
10. Jin CY, Zhu BS, Wang XF, Lu QH. 2008. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21: 1871-1877.
11. Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilanic?ová D, Wallin H, et al. 2012. In vitro assessment of engineered nanomaterials using C3A cells: cytotoxicity, pro-inflammatory cytokines and function markers. Nanotoxicology; ahead of print.
12. Kim BS, Park IK, Hoshiba T, Jiang HL, Choi YJ, Akaike Y, et al. 2011. Design of artificial extracellular matrices for tissue engineering. Prog Polym Sci 36:238-268.
13. Kmiec Z. 2001. Co-operation of liver cells in health and disease. Advances in Anatomy. Embryol Cell Biol 161:1-151.
14. Liguori MJ, Blomme EAG, Waring JF. 2008. Trovafloxacin induced gene expression changes in liver derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells. Drug Metab Dispos 36:223-233.
15. Liu C, Tsai AL, Chen YC, Fan SH, Huang CH, Wu CC, et al. 2012. Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury. J Cell Biochem 113:148-155.
16. Maynard AD, Aitkin RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, et al. 2006. Safe handling of nanotechnology. Nature 444:267-269.
17. Mingoia RT, Nabb DL, Yang CH, Han X. 2007. Primary culture of rat hepatocytes in 96 well plates: Effects of extracellular matrix configuration on cytochrome P450 enzyme activity and inducibility and its application in vitro cytotoxicity screening. Toxicol In Vitro 21:165-173.
18. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 42:1-35.
19. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, et al. 2011. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondrial involved apoptosis. Toxicol Lett 201:92-100.
20. Pichardo S, Gutierrez-Praena D, Puerto M, Sanchez E, Grilo A, Camean AM, et al. 2012. Oxidative stress responses to carboxylic acid functionalized single wall carbon nanotubes on the human intestinal cell line Caco-2.
21. Toxicol In Vitro; ahead of print. Raffa V, Gherardini L, Vittorio O, Bardi G, Ziaei A, Pizzorusso T, et al. 2011. Carbon nanotube-mediated wireless cell permeabilization: drug and gene uptake. Nanomedicine 6:1709-1718.
22. Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr R. 2006. Interaction of fine particles and nanoparticles with red blood cells visualised with advanced microscopic techniques. Environ Sci Technol 40:4353-4359.
23. Saad B, Frei K, Scholl FA, Fontana A, Maier P. 1995. Hepatocyte-derived interleukin-6 and tumour-necrosis factor alpha mediate the lipopolysaccharide- induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur J Chem 229:349-355.
24. Sadauskas E, Jacobson NR, Danscher G, Soltenberg M, Larsen A, Kreyling W, et al. 2009. Bio-disruption of gold nanoparticles in mouse lung following intratracheal instillation. Chem Central J 3:16-23.
25. Sahi J, Grepper S, Smith C. 2010. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr Drug Discov Technol 7:188-198.
26. Semmler-Behnke M, Wolfgang KG, Lipka J, Fertsch S, Wenk A, Takeneka S, et al. 2008. Bio-distribution of 1.4 and 18 nm gold particles in rats. Small 12:2108-2111.
27. Sharma V, Anderson D, Dhawan A. 2011. Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J Biomed Nanotechnol 7:98-99.
28. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. 2012. Mechanism of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicol Appl Pharmacol; ahead of press.
29. Tetley TD. 2007. Health effects of nanomaterials. Bionanotechnology 35:527-531.
30. Villeneuve JP, Pichette V. 2004. Cytochrome P450 and the liver diseases. Curr Drug Metab 5:273-282.
31. Wang YG, Aker WG, Hwang HM, Yedjou CG, Yu HT, Tchounwou PB. 2011. A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary heaptocytes and human HepG2 cells. Sci Total Environ 409:4753-4762.
32. Wanninger J, Neumeier M, Weigert J, Bauer S, Weiss TS, Schaffler A, et al. 2009. Adiponectin stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF kappa B and STAT 3 signalling pathways. Am J Physiol Gastrointestin Liver Physiol 297:611-618.
33. Westerink WMA, Schoonen WGEJ. 2007. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1581-1591.
34. Woodrow Wilson. Available online at http://www.nanotechproject.org/ inventories/consumer/browse/products/.Accessed 16-1-2012.
35. Wongkajornslip A, Sa-Ngiamsuntorn K, Hongeng S. 2012. Development of immortalized Hepatocyte-like cells from hMSCs. Methods Mol Biol 826:73-87.